Tonix Pharmaceuticals, Inc.
26 Main Street – Suite 101
Chatham
New Jersey
07928
United States
Website: http://www.tonixpharma.com/
413 articles about Tonix Pharmaceuticals, Inc.
-
TONIX Pharmaceuticals, Inc. Reports Fourth Quarter And Full Year 2014 Financial Results
3/3/2015
-
TONIX Pharmaceuticals, Inc. To Present At The 8th Annual European Life Sciences CEO Forum
3/2/2015
-
TONIX Pharmaceuticals, Inc. Announces Closing Of $28.7 Million Public Offering Of Common Stock
2/9/2015
-
TONIX Pharmaceuticals, Inc. To Present At The BIO CEO & Investor Conference
2/5/2015
-
TONIX Pharmaceuticals, Inc. Prices Underwritten Public Offering Of Common Stock
2/4/2015
-
TONIX Pharmaceuticals, Inc. Announces Proposed Public Offering Of Common Stock
2/4/2015
-
TONIX Pharmaceuticals, Inc. Commences Phase 2 Trial Of TNX-102 SL In Post-Traumatic Stress Disorder
1/15/2015
-
TONIX Pharmaceuticals, Inc. To Present At The Noble Financial Annual Investor Conference
1/14/2015
-
TONIX Pharmaceuticals, Inc. Announces Clinical Progress On Potential Treatment for Headache
1/9/2015
-
TONIX Pharmaceuticals, Inc. Provides Clinical And Regulatory Update On Its Continued Development Of TNX-102 SL In Fibromyalgia
1/6/2015
-
TONIX Pharmaceuticals, Inc. To Present At The LD Micro Investor Conference
11/25/2014
-
TONIX Pharmaceuticals, Inc. Reports Third Quarter 2014 Financial Results
11/10/2014
-
TONIX Pharmaceuticals, Inc. Receives IND Clearance For TNX-201 In Episodic Tension-Type Headache
10/21/2014
-
TONIX Pharmaceuticals, Inc.'s Pain Drug Fails Phase 2b Study
9/29/2014
-
TONIX Pharmaceuticals, Inc. To Present At The Biocentury Newsmakers Conference
9/19/2014
-
TONIX Pharmaceuticals, Inc. To Present At The Rodman & Renshaw Global Investment Conference
9/3/2014
-
TONIX Pharmaceuticals, Inc. Announces Transfer To The NASDAQ Global Market
8/11/2014
-
TONIX Pharmaceuticals, Inc. Reports Second Quarter 2014 Financial Results
8/8/2014
-
TONIX Pharmaceuticals, Inc. To Present At Two Investor Conferences In August
8/6/2014
-
TONIX Pharmaceuticals, Inc. Announces Registered Direct Offering Of $7.8 Million
7/11/2014